To successfully reopen the U.S. economy, public health agencies must perform extensive contact tracing to keep new cases of the virus from growing into a larger outbreak.
Check out our latest infographic to visualize how contact tracing works.
Explore our Clinical Watch Newsletter
Learn More
In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the management of schizophrenia and suggest prior authorization criteria for a new treatment for Cushing
Conduent can help states to swiftly and seamlessly implement their Electronic Visit Verification EVV Program. Learn how.
In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding
In this issue of Clinical Watch, we highlight the use of diabetes drugs in the treatment of heart failure and suggest prior authorization criteria for the first approved treatment of plexiform neurofi
In this issue of Clinical Watch, we highlight the NIH Panel recommendations regarding medications associated with COVID-19 treatment and suggest prior authorization criteria for the first approved tre
In this issue of Clinical Watch, we highlight aspects of Medicaid programs that are affected COVID-19 and suggest prior authorization criteria for a new lipid-lowering drug.
The need for timely, accurate information-sharing among key healthcare stakeholders is crucial to preventing the spread of COVID-19.
2:18Conduent's cloud-based COVID-19 module empowers public health authorities and private organizations with contact tracing to monitor, track, and report on confirmed COVID-19 cases along with those expo
In this issue of Clinical Watch, we discuss COVID-19 and suggest prior authorization criteria for immunotherapy to reduce the severity of allergic reactions to peanuts.
